Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Hematological Inflammatory Indexes be Used to Differentiate Type 1 Modic Changes From Brucella Spondylodiscitis

NCT06432530 is registered in ClinicalTrials.gov with Yuzuncu Yil University as lead sponsor.

NCT NCT06432530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06432530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Hematological Inflammatory Indexes be Used to Differentiate Type 1 Modic Changes From Brucella Spondylodiscitis
Lead sponsor
Yuzuncu Yil University
Phase
Observational
Overall status
Completed
Start date
January 9, 2023
Completion date
March 8, 2024
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brucella spondylitis